Introduction
============

A chronic low-grade inflammatory state of adipose tissue has been implicated in the development of insulin resistance in non-pregnant (NP) obese subjects ([@bib30], [@bib32]). Adipocytes in obesity increase triglyceride accumulation, resulting in hypertrophy and adipose tissue remodeling. Hypertrophied adipocytes release monocyte chemoattractant protein 1 (MCP1; [@bib17]), which activates blood monocytes through CC chemokine receptor 2 (CCR2) and induces monocyte migration to adipose tissue and differentiation into macrophages. CCR2 also plays a key role in monocyte/macrophage recruitment and macrophage-dependent inflammatory response ([@bib3]). Mouse models demonstrated that accumulation of macrophages into adipose tissue via the MCP1/CCR2 pathway is necessary for the development of insulin resistance related to obesity ([@bib31]). Although it has been reported that hypertrophy of adipocyte results in late pregnancy ([@bib19]), little is known about whether such an inflammatory change actually occurs.

Macrophages in adipose tissue are activated in response to free fatty acids (FFA), whereby they are released from hypertrophied or dead adipocytes, producing larger amounts of inflammatory factors such as tumor necrosis factor α (TNFα), interleukin 6 (IL6), plasminogen activator inhibitor type 1 (PAI1), MCP1, and others, which, in turn, augment the release of FFA and inflammatory changes in adipocytes ([@bib28]). In addition, macrophage-derived MCP1 further induces blood monocytes to differentiate macrophages and recruits them into adipose tissue, establishing a vicious cycle that aggravates inflammatory changes in NP obese adipose tissue. Accumulation of macrophages in adipose tissue seems to be a feature characteristic to expanding adipose tissue.

A recent study has shown that different stimuli activate macrophages in adipose tissue to express distinct patterns of chemokines, surface markers, and metabolic enzymes that ultimately generate the diversity of macrophage function seen in inflammatory and non-inflammatory settings, and macrophages in adipose activation have been operationally defined into separate polarization stats, M1 and M2 ([@bib21]). The M1 macrophages produce TNFα, IL6, and nitric oxide. In contrast, the M2 macrophages produce anti-inflammatory cytokines IL10 and arginase ([@bib18]). [@bib12] used microarray analysis to demonstrate that the M1 macrophage markers include CD11c, TNFα, IL6, and MCP1, and the M2 macrophage marker is IL10.

We previously reported that the weight of adipose tissue physiologically increases during pregnancy ([@bib19]). However, whether the physiological increase in adipose tissue during pregnancy accompanies an increase in macrophage infiltration into adipose tissue and whether the inflammatory changes of adipose tissue exist in late pregnancy are factors that remain unexplained.

A hypothesis of this study was that a low-grade inflammatory status in adipose tissue occurs in late pregnancy, including accumulation of M1 macrophages in the adipose tissue, as well as in NP obese subjects. To demonstrate whether the inflammatory change in adipose tissue also occurs in late pregnancy, pregnant mice were used to examine adipocyte size, the changes in the infiltration of M1 and M2 macrophages, serum adipokine levels, and the gene expression of adipokines in subcutaneous adipose tissue (SAT) and parametrial adipose tissue (PAT).

Materials and methods
=====================

Experimental animals and diets
------------------------------

All experimental protocols with mice were approved by the Animal Ethics Committee of Mie University. Charles River (Osaka, Japan) supplied the 5-week-old *C57BL/6N* female mice. These mice were fed a normal chow diet (10% energy from fat, 70% from carbohydrate, and 20% from protein; catalog no. D12450B; Research Diets, Inc., New Brunswick, NJ, USA) and were mated only once at 10 weeks of age. All mice were maintained under a 12 h light:12 h darkness cycle and had access to food and water *ad libitum* unless indicated. The presence of a plug was regarded as embryonic day 0 (E0). The mice that failed to achieve pregnancy were placed into the NP group. Finally, 32 control and 26 pregnant mice were used for the experiment. The body weight was measured daily. The mice were dissected at E17 after a 14--16 h fast. Dams with a litter size of 7--9 were included as experimental subjects in this study, i.e. pregnant group, and the remaining dams were redirected.

Collection of blood and tissue samples
--------------------------------------

The mice were killed at E17. Blood was collected, allowed to clot, and spun at 800 ***g*** to collect serum. The SAT and PAT were removed. Adipose tissues were fixed in 4% paraformaldehyde (Nakarai Tesque, Kyoto, Japan), and the other tissues were frozen in liquid nitrogen and stored at −80 °C prior to RNA extraction.

Metabolic testing
-----------------

For glucose tolerance test (GTT), the mice were deprived of food for 14--16 h overnight and then given peritoneal injections of glucose (2 g/kg body mass; Otsuka Pharmaceutical Co. Ltd, Tokusima, Japan) at E17. For insulin tolerance test (ITT), the mice were deprived of food for 3 h at E16 and then given peritoneal injections of human regular insulin (0·75 U/kg body mass; Eli Lilly and Co.). The mice that received ITT did not receive GTT. Thus, 32 control mice received either GTT (*n*=17) or ITT (*n*=15). A number (16) of the pregnant mice also received either GTT (*n*=9) or ITT (*n*=7). Blood samples were collected before and 15, 30, 60, and 120 min after injection, and plasma glucose was measured with a One Touch Ultra instrument (Lifescan, Inc., Tokyo, Japan).

Analysis of metabolic parameters
--------------------------------

All serum measurements were made after fasting for one night. Serum FFA levels were measured using NEFA-C (Wako Pure Chemical Industries, Inc., Osaka, Japan). The serum concentrations of mouse MCP1, IL6, and IL10 were measured using ELISA kits (R&D Systems, Minneapolis, MN, USA). The serum concentrations of mouse TNFα were measured using mouse TNFα ELISA Kits (Shibayagi Co. Ltd, Shibukawa, Japan). The serum adiponectin levels were measured using an adiponectin ELISA Kit (Otsuka Pharmaceutical Co. Ltd).

Immunohistochemical study
-------------------------

Adipose tissues were fixed in 4% paraformaldehyde in 0·01 M sodium PBS (pH 7·4) for 14 h at 4 °C. The fixed samples were embedded in paraffin (Merck Co. Ltd) and cut into 7 μm-thick sections. The sections were mounted on glass slides coated with triethoxyaminopropylsilane (Dako ChemMate, Kyoto, Japan).

Adipose sections were deparaffinized with xylene and rehydrated through graded concentrations of ethanol. The sections were stained with hematoxylin and eosin, adipocyte size was counted from ten fields on each section, and 50 adipocytes were counted from one field using WinRoof 5.7 Software (Mitani Corp., Fukui, Japan).

CD68 is known to be not only a typical phagocytic marker but also an indicator of macrophage number ([@bib8]). Therefore, the definition of the macrophages was analyzed using anti-CD68 antibody. For antigen retrieval, deparaffinized sections were microwaved for 5 min in citric acid buffer (pH 6·0). Tissue sections were quenched with peroxidase blocking solution (1% H~2~O~2~) for 15 min and blocked with 1% normal goat serum for 30 min. Tissue sections were incubated overnight with mouse anti-CD68 monoclonal antibody (1:50, Imgenex Corp., San Diego, CA, USA). The sections were incubated with anti-mouse IgG--HRP (1:200, Medical & Biological Laboratories Co. Ltd, Nagoya, Japan) for 3 h after washing. The reaction product was visualized by incubation with DAB substrate chromogen and immersed in distilled water. Tissue sections were counterstained with hematoxylin for 2 min and rinsed with distilled water, dehydrated by sequential immersion in gradient ethanol and xylene, then mounted with Entellan New (Merck KGaA), and coverslipped. To evaluate the degree of infiltration by macrophages, adipocytes and macrophages were counted from 30 fields on each section, with macrophages expressed as percentage of the total adipocytes counted.

The definition of the macrophage subtypes was assessed using a double immunofluorescence labeling study. Briefly, sections were incubated for 60 h with rat monoclonal anti-F4/80 antibody (1:50, Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) and hamster monoclonal anti-CD11c (1:25, AbD Serotec, Kidlington, UK). Alexa 594-labeled antibody against rat IgG and IgM antibodies and Alexa 488-labeled goat antibody against hamster IgG antibody (1:400, Molecular Probes, Inc., Eugene, OR, USA) were incubated for 3 h. The stained sections were examined under an inverted laser scan microscope (Fluoview FV1000, Olympus, Tokyo, Japan). Tissue sections were mounted with Thermo (Thermo Fisher Scientific Anatomical Pathology, Kalamazoo, MI, USA) and coverslipped. A number (6) of specimens were randomly selected from each group, NP and pregnant, and then the number of cells was counted per microscopic field. F4/80 is a marker of mature macrophages ([@bib17]). CD11c is a M1 macrophage-specific marker, and F4/80^+^ CD11c^+^ cells in adipose tissue are known to be a specific population of macrophages recruited to adipose tissue that subsequently overexpress inflammatory genes like M1 macrophages ([@bib21], [@bib12]). Therefore, cells in which both F4/80 and CD11c were positive were regarded as M1 macrophages, and the cells that were F4/80 positive and CD11c negative were regarded as M2 macrophages. However, we cannot clearly distinguish between M1 macrophages and M2 macrophages by this method.

RNA isolation, RT-PCR, and quantitative real-time PCR
-----------------------------------------------------

Total RNA was extracted from adipose tissues with the use of a Sepasol-RNA1 Super according to the manufacturer\'s instructions (Nakarai Tesque), and portions (10--15 μg) of the isolated RNA were subjected to real-time quantitative PCR analysis. Gene expression was quantified as a two-step RT-PCR. cDNA synthesized from total RNA was analyzed using TaqMan reverse transcription reagents and a TaqMan Gold RT-PCR Kit (Applied Biosystems, Carlsbad, CA, USA) according to the manufacturer\'s instructions. All PCRs were performed using a real-time PCR 7300 system with specific primers and a PCR Master Mix (Applied Biosystems). Assays were performed in 50 μl of single--plex reaction mixture. Reaction conditions consisted of pre-incubation at 50 °C for 2 min and 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s and 60 °C for 1 min. The concentration values were automatically recorded. Quantitative RT-PCR data are presented as the mean±[s.e.m]{.smallcaps}. (arbitrary units).

The relative abundance of mRNAs was calculated with *GAPDH* (20×, 4352932E) as the internal control. The target genes were as follows: mouse *CD68* (Mm00839636_ml), *Emrl* (Mm00802529_ml, encoding F4/80), *Itgax* (Mm00498698_ml, encoding CD11c), *MCP1* (Mm00441242_ml), *CCR2* (Mm99999051_ml), *TNFα* (Mm00443258_ml), *IL6* (Mm00446190_ml), *PAI1* (Mm00436753_ml), adiponectin (Mm456425_ml), and *IL10* (Mm0043616_ml).

Statistical analysis
--------------------

Results are shown as the mean±[s.e.m]{.smallcaps}. Statistical analysis was performed using the SPSS 11.0 Software (SPSS Inc., Chicago, IL, USA). The two-way ANOVA was performed for GTT and ITT and the two-tail Student\'s *t*-test was performed for the others. Significance was considered to be *P*\<0·05.

Results
=======

Comparing the NP and the pregnant groups for body weight and glucose and insulin tolerance
------------------------------------------------------------------------------------------

The body weight of the NP group was the same as that of the pregnant group before mating. However, the body weight in the pregnant group was significantly heavier than that in the NP group during pregnancy (18·3±2·6 vs 29·7±1·3 g, *P*=0·0001; [Fig. 1A](#fig1){ref-type="fig"}).

GTT was performed to compare glucose tolerance between the pregnant group and the NP group. The results are shown in [Fig. 1B](#fig1){ref-type="fig"}. A deterioration was detected in glucose tolerance during GTT at 30 and 60 min (30 min: F(1·25)=4·93, *P*=0·04; 60 min: F(1·25)=11·2, *P*=0·003).

ITT was performed to evaluate the degree of insulin resistance. The percent reduction of glucose concentration in the pregnant group was significantly less than that in the NP group at 30, 60, and 120 min (30 min: F(1·21)=17·2, *P*=0·0005; 60 min: F(1·21)=9·46, *P*=0·006; 120 min: F(1·21)=15·9, *P*=0·0007; [Fig. 1C](#fig1){ref-type="fig"}).

Comparisons of the weight of adipose tissue, size of adipocytes, and degree of macrophage infiltration into adipose tissue between the NP and the pregnant groups
-----------------------------------------------------------------------------------------------------------------------------------------------------------------

The weight of adipose tissue for both SAT and PAT was significantly higher in the pregnant group than that in the NP group (SAT: 0·26±0·04 vs 0·50±0·02 g, *P*=0·0001 and PAT: 0·18±0·02 vs 0·25±0·02 g, *P*=0·008; [Fig. 2A](#fig2){ref-type="fig"}).

The sizes of adipocytes were measured using sections stained with hematoxylin and eosin, using the WinRoof 5.7 Software. The sizes of adipocytes in both SAT and PAT were significantly greater in the pregnant group than those in the NP group (SAT: 8·20±0·89 vs 12·09±2·36 μm, *P*=0·003; PAT: 9·29±1·36 vs 11·58±0·20 μm, *P*=0·003; [Fig. 2B](#fig2){ref-type="fig"}).

Macrophage infiltration in the pregnant group increased 2·1-fold in SAT ([Fig. 2C and D](#fig2){ref-type="fig"}) and increased 1·4-fold in PAT ([Fig. 2E and F](#fig2){ref-type="fig"}) compared with that in the NP group (SAT: 31·84±2·04 vs 15·1±1·57%, *P*=0·002; PAT: 31·5±2·45 vs 22·86±1·84%, *P*=0·027).

Serum measurements
------------------

Serum FFA levels in the pregnant group significantly increased compared with those in the NP group (1·06±0·08 vs 0·65±0·05 mEq/l, *P*=0·001; [Fig. 3A](#fig3){ref-type="fig"}). Serum MCP1 levels showed no significant difference between the pregnant group and the NP group (39·40±6·13 vs 33·25±3·87 pg/ml, *P*=0·24; [Fig. 3B](#fig3){ref-type="fig"}). Serum levels of TNFα and IL6 in the pregnant group increased compared with those in the NP group (TNFα: 112·97±10·60 vs 34·41±6·66 pg/ml, *P*=0·0001; IL6: 26·79±6·02 vs 9·90±1·24 pg/ml, *P*=0·037; [Fig. 3C and D](#fig3){ref-type="fig"}). Serum levels of IL10 in the pregnant group significantly increased compared with those in the NP group (IL10: 30·74±4·89 vs 8·93±1·42 pg/ml, *P*=0·002; [Fig. 3E](#fig3){ref-type="fig"}). Serum adiponectin levels in the pregnant group decreased 40% compared with those in the NP group (adiponectin: 25 098·01±1319·73 vs 42 310·66±2153·16 ng/ml, *P*=0·0001; [Fig. 3F](#fig3){ref-type="fig"}).

The immunohistochemical analyses of macrophage subtypes in adipose tissue
-------------------------------------------------------------------------

To assess the changes between M1 and M2 macrophages, double immunofluorescence staining with anti-F4/80 antibody and anti-CD11c antibody was performed. The M1/M2 ratio in the pregnant group displayed a 6·5-fold increase in SAT ([Fig. 4A and B](#fig4){ref-type="fig"}) and a 7·0-fold increase in PAT ([Fig. 4C and D](#fig4){ref-type="fig"}) compared with that in the NP group (SAT: 3·69±0·57 vs 0·41±0·09, *P*=0·0002; PAT: 5·68±0·86 vs 0·81±0·09, *P*=0·0002).

The gene expression of adipokines in adipose tissue
---------------------------------------------------

Gene expression was investigated as it is related to macrophage function. *CD68* is known to be a macrophage marker for phagocytosis. The pregnant group showed a significant increase in both SAT and PAT compared with the NP group (SAT: *P*=0·017; PAT: *P*=0·0001; [Fig. 5A](#fig5){ref-type="fig"}). Compared with the NP group, *Emrl* gene expression by the pregnant group was decreased by 50% in SAT and increased 4·7-fold in PAT (SAT: *P*=0·047; PAT: *P*=0·0001; [Fig. 5B](#fig5){ref-type="fig"}). CD11c is an indicator of macrophage subtype classification encoded by *Itgax*. *Itgax* mRNA levels in the pregnant group significantly increased in both SAT and PAT compared with those in the NP group (SAT: *P*=0·018; PAT: *P*=0·02; [Fig. 5C](#fig5){ref-type="fig"}).

*MCP1* mRNA levels displayed no significant difference between the NP group and the pregnant group in SAT (*P*=0·57). However, in PAT, the pregnant group markedly increased compared with the NP group (*P*=0·0001; [Fig. 5D](#fig5){ref-type="fig"}). *CCR2* mRNA levels were significantly higher in the pregnant group compared with those in the NP group in SAT (*P*=0·046). However, in PAT, there was no significant difference between the two groups (*P*=0·92; [Fig. 5E](#fig5){ref-type="fig"}).

We assessed the gene expression of pro-inflammatory factors such as *TNFα, IL6*, and *PAI1* and anti-inflammatory factors such as *IL10* and adiponectin. *TNFα* mRNA levels in the pregnant group significantly increased in both SAT and PAT compared with those in the NP group (SAT: *P*=0·004; PAT: *P*=0·002; [Fig. 5F](#fig5){ref-type="fig"}). The pregnant group increased *IL6* gene expression in PAT (*P*=0·036) compared with the NP group, but not SAT (*P*=0·83; [Fig. 5G](#fig5){ref-type="fig"}). The *PAI1* mRNA levels in the pregnant group markedly increased in both SAT and PAT compared with those in the NP group (SAT: *P*=0·001; PAT: *P*=0·002; [Fig. 5H](#fig5){ref-type="fig"}).

Adiponectin mRNA levels were significantly higher in the pregnant group compared with those in the NP group in PAT (*P*=0·0006), but not in SAT (*P*=0·56; [Fig. 5I](#fig5){ref-type="fig"}). *IL10* mRNA levels showed a tendency similar to adiponectin (PAT: *P*=0·0018; SAT: *P*=0·21; [Fig. 5J](#fig5){ref-type="fig"}).

Discussion
==========

In this study, the pregnant mice model displayed glucose intolerance and insulin resistance, which was also demonstrated in previous reports ([@bib14], [@bib26]). In late pregnancy, we previously showed that the diameter of parametrial adipocytes increases 1·2-fold in mice compared with NP mice ([@bib19]). In this study, the size of subcutaneous adipocytes and parametrial adipocytes was 1·4- and 1·3-fold more, respectively, than that of the control subject. Adipocyte hypertrophy is reportedly related to macrophage infiltration of adipose tissue ([@bib7], [@bib25]). Therefore, we examined whether inflammatory changes in adipose tissue occur in late pregnancy and found that inflammatory changes are in fact induced by macrophage infiltration in adipose tissue in late pregnancy.

This study showed that the pregnant mice model displayed the infiltration of macrophages into adipose tissue with an increase in the M1/M2 ratio for both SAT and PAT, suggesting that the inflammatory changes occur in adipose tissue in late pregnancy ([Figs 2](#fig2){ref-type="fig"} and [4](#fig4){ref-type="fig"}). These inflammatory changes are similar to those in NP obese subjects ([@bib11]). The gene expression of pro-inflammatory adipokines such as *TNFα, IL6*, and *PAI1* significantly increased, and the anti-inflammatory adipokine *IL10* also significantly increased ([Fig. 5](#fig5){ref-type="fig"}), which is consistent with NP obese subjects ([@bib30], [@bib32], [@bib17], [@bib27]). However, the serum levels of FFA, TNFα, IL6, and IL10 increased and adiponectin decreased ([Fig. 3](#fig3){ref-type="fig"}). These results suggest that the inflammatory changes occur during pregnancy not only in the adipose tissue but also at the systemic level. Also, these results are consistent with the hypothesis of this study, which states that increased M1 macrophage recruitment to adipose tissue causes an increase in the gene expression of pro-inflammatory adipokines such as *TNFα* and *IL6*, which leads to secretion into the blood, and contributes to the inflammatory changes in late pregnancy.

MCP1 is known to be a key initiator of macrophage infiltration into adipose tissue, so that changes to MCP1 and to its receptor, CCR2, are important. Although serum levels of MCP1 were not increased in the pregnant group in this study, *MCP1* mRNA levels in pregnant PAT were higher than those in NP PAT. Also, although *CCR2* mRNA levels in pregnant SAT were similar to those in NP SAT, there were no significant changes between pregnant and NP PAT. However, if the gene expression is adjusted by arbitrary units per total DNA of either SAT or PAT, mRNA levels of both MCP1 and CCR2 in pregnant SAT and PAT were higher than those in NP SAT and PAT respectively (data not shown). Taken together, these results are consistent with the theory that macrophage recruitment into adipose tissue is involved in the MCP1/CCR2 pathway in late pregnancy.

In the case of the NP obese mouse model, PAT is reportedly much more involved in pro-inflammatory changes compared with SAT ([@bib30], [@bib23]). In this study, the PAT showed similar changes with the SAT. Therefore, the role of pro-inflammatory changes between SAT and PAT in late pregnancy is not yet clear, and further study is needed.

TNFα is produced not only from monocytes and macrophages but also from T-cells, neutrophils, fibroblasts, and adipocytes ([@bib2]). This study revealed that the serum TNFα levels and *TNFα* gene expression in adipose tissue significantly increased in late pregnancy ([Figs 3C](#fig3){ref-type="fig"} and [5F](#fig5){ref-type="fig"}). The serum TNFα levels have been correlated to body mass index (BMI) or hyperinsulinemia in obese animals and humans ([@bib15], [@bib16]). Previous studies revealed that TNFα impaired insulin signaling by increasing serine phosphorylation of the insulin receptor substrate 1 (IRS1) and by diminishing insulin receptor tyrosine kinase activity ([@bib15], [@bib24]). Therefore, TNFα may be involved in insulin resistance in the present pregnant mice model.

IL6 underwent the same changes as TNFα at the serum and mRNA levels in this study. IL6 contributed to insulin resistance by impairing insulin signaling in the liver and in adipocytes and by inducing ubiquitin-mediated degradation of the IRS1 through the suppression of cytokine signaling 1 (SOCS1) and SOCS3 ([@bib9], [@bib20]). There was a different gene expression of IL6 between SAT and PAT in this study. However, when the gene expression was adjusted by arbitrary units per total DNA of either SAT or PAT, serum levels and gene expression of pro-inflammatory cytokines were almost consistent, and, therefore, serum levels of these factors reflected adipose tissue as the main source in this study. We cannot exclude the possibility that other sources such as placenta produce these cytokines.

The IL10 is an anti-inflammatory cytokine and is a critical effector molecule of M2 macrophages. The serum IL10 levels and the mRNA levels of *IL10* were increased in pregnant subjects in this study, which was consistent with NP obese subjects ([@bib27], [@bib11]). A previous study demonstrated that IL10 protected against TNFα-dependent insulin resistance in adipocytes via activation of STAT3 ([@bib21]) and modulated the transcription rates of inflammatory genes such as *TNFα* and *MCP1* ([@bib22]). Therefore, IL10 may compensate for changes in M1-dominant adipokines during late pregnancy. However, there is a possibility that the increase in IL10 is caused by the increase in M2-related macrophages.

Serum adiponectin levels decreased in late pregnancy in this study, which was consistent with previous studies ([@bib6], [@bib19]). However, adiponectin gene expression increased in adipose tissue in the current study, which was inconsistent with previous reports on NP obesity ([@bib1], [@bib5]), leading to a possibility that adiponectin secretion was decreased in the present model. In fact, a posttranslational mechanism controlling adiponectin levels has been reported ([@bib29]). Circulating levels of adiponectin have been shown to correlate with whole-body insulin resistance through adiponectin receptors in skeletal muscle and liver ([@bib13]). From reports that TNFα and IL6 suppress the transcription of adiponectin in adipocytes ([@bib4], [@bib10]), the increase in TNFα and IL6 serum levels and decrease in adiponectin serum levels in this study may be involved in insulin resistance in late pregnancy.

In this study, the imbalance between M1 and M2 macrophages induced by adipocyte hypertrophy broke the balance between inflammatory and anti-inflammatory adipokines, which eventually led to inflammatory changes of adipose tissue in late pregnancy. Inflammatory changes of adipose tissue may be involved in insulin resistance as a physiological adaptation to maintain maternal and fetal metabolism in late pregnancy.
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![Comparison of body weight and metabolic profiles between the P group and the NP group. (A) Changes in body weight of the NP group (*n*=32) and the P group (*n*=26) before and during pregnancy. E10, embryonic day 10; E16, embryonic day 16. (B) Circulating glucose levels were measured during a glucose tolerance test (NP, *n*=17; P, *n*=9). GTT points were normalized to the baseline glucose levels at 0 min. (C) Plasma glucose level during the insulin tolerance test (NP, *n*=15; P, *n*=7). ITT points were normalized to the baseline glucose levels at 0 min. Data are presented as the mean±[s.e.m]{.smallcaps}. For body weight, a two-tail Student\'s *t*-test was performed, and two-way ANOVA was performed for glucose and insulin tolerance. P versus NP: \**P*\<0·05, \*\**P*\<0·01, \*\*\**P*\<0·001.](JME110030f01){#fig1}

![The effect of pregnancy on adipose tissue weight, adipocyte hypertrophy, and macrophage infiltration. (A) Weight of subcutaneous and parametrial adipose tissue of the NP group (*n*=32) and the P group (*n*=26). (B) Adipocyte size of subcutaneous and parametrial adipose tissue was measured using WinRoof 5.7 (*n*=6 per group). (C) The infiltration of macrophages into SAT was revealed by immunohistochemical study using anti-CD68 antibody (*n*=6 per group). (D) Quantitative analysis of the degree of macrophages infiltrated into SAT (*n*=6 per group). (E) Immunohistochemical localization of CD68-positive macrophages in PAT (*n*=6 per group). (F) Quantitative analysis of the degree of macrophages infiltrated into PAT (*n*=6 per group). Data are presented as the mean±[s.e.m]{.smallcaps}. The two-tail Student\'s *t*-test was performed. P versus NP: \**P*\<0·05, \*\**P*\<0·01, \*\*\**P*\<0·001.](JME110030f02){#fig2}

![Serum measurements between the P group and the NP group. (A) Serum fasting FFA levels of the NP group (*n*=6) and the P group (*n*=7). (B) Serum MCP1 levels of the NP group (*n*=10) and the P group (*n*=9). (C) Serum TNFα levels of the NP group (*n*=11) and the P group (*n*=7). (D) Serum IL6 levels of the NP group (*n*=9) and the P group (*n*=10). (E) Serum IL10 levels of the NP group (*n*=9) and the P group (*n*=11). (F) Serum adiponectin levels of the NP group (*n*=10) and the P group (*n*=8). Data are presented as the mean±[s.e.m]{.smallcaps}. A two-tail Student\'s *t*-test was performed. P versus NP: \**P*\<0·05, \*\**P*\<0·01, \*\*\**P*\<0·001.](JME110030f03){#fig3}

![The definition of macrophage subtypes in adipose tissue from non-pregnant and pregnant mice. (A) Identification of F4/80^+^ CD11c^+^ macrophages by immunofluorescence microscopy in the frozen sections of SAT stained with antibodies against F4/80 (left) and CD11c (middle) and imaged by confocal microscopy to identify surface markers to confirm the presence of CD11c^+^ cells. F4/80^+^ CD11c^+^ macrophage: M1 macrophage; F4/80^−^ CD11c^+^ macrophage: M2 macrophage (*n*=6 per group). (B) The ratio of M1--M2 macrophages in SAT (*n*=6 per group). (C) Identification of F4/80^+^ and CD11c^+^ macrophages in PAT by immunofluorescence microscopy (*n*=6 per group). (D) The ratio of M1--M2 macrophages in PAT (*n*=6 per group). Data are presented as the mean±[s.e.m]{.smallcaps}. A two-tail Student\'s *t*-test was performed. P versus NP: \*\*\**P*\<0·001.](JME110030f04){#fig4}

![Gene expressions of inflammatory and anti-inflammatory adipokines in adipose tissue between the P group and the NP group. (A) *CD68* gene expression of the NP group (*n*=10) and the P group (*n*=13). (B) *Emrl* gene expression of the NP group (*n*=10) and the P group (*n*=18). (C) *Itgax* gene expression of the NP group (*n*=10) and the P group (*n*=18). (D) *MCP1* gene expression of the NP group (*n*=8) and the P group (*n*=12). (E) *CCR2* gene expression of the NP group (*n*=9) and the P group (*n*=10). (F) *TNFα* gene expression of the NP group (*n*=10) and the P group (*n*=17). (G) *IL6* gene expression of the NP group (*n*=6) and the P group (*n*=8). (H) *PAI1* gene expression of the NP group (*n*=7) and the P group (*n*=11). (I) Adiponectin gene expression of the NP group (*n*=10) and the P group (*n*=16). (J) *IL10* gene expression of the NP group (*n*=8) and the P group (*n*=9). Macrophage-related adipokine gene expression was evaluated by real-time quantitative RT-PCR. Data are presented as the mean±[s.e.m]{.smallcaps}. A two-tail Student\'s *t*-test was performed. P versus NP: \**P*\<0·05, \*\**P*\<0·01, \*\*\**P*\<0·001.](JME110030f05){#fig5}
